Effects on cerebral blood flow after single doses of the β 2 agonist, clenbuterol, in healthy volunteers and patients with mild cognitive impairment or Parkinson's disease.
Thomas LodeweyckxJan de HoonKoen Van LaereEdgar BautistaGaia RizzoCourtney BishopEugenii RabinerRenee S MartinAnthony FordGabriel VargasPublished in: British journal of clinical pharmacology (2024)
-AR antagonism in the periphery was achieved without interrupting the central effects of clenbuterol on rCBF.